Wal-Mart.com USA, LLC
Wal-Mart.com USA, LLC
Wal-Mart.com USA, LLC

ThromboGenics Presents Positive Pooled Results from the MIVI-TRUST Phase III Program, Confirming Microplasmin's ...

6 September 2010, 12:28 am

LEUVEN, Belgium, September 6, 2010 /PRNewswire-FirstCall/ -- - Data Presented at EURETINA Highlight the Attractive Characteristics of this Novel Potential Treatment Option for Retinal Disorders ThromboGenics NV (Euronext Brussels: THR), a biopharmaceutical company focused on the discovery and development of innovative treatments for eye disease, cardiovascular disease and cancer, announces that ...... Read More »

Wal-Mart.com USA, LLC